LOGIN
Oral Vs Intravenous Tranexamic Acid For Perioperative Blood Loss After Total Hip Arthroplasty
June 2024
Oral Vs Intravenous Tranexamic Acid For Perioperative Blood Loss After Total Hip Arthroplasty
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Oral as compared to intravenous tranexamic acid to limit peri-operative blood loss associated with primary total hip arthroplasty: A randomised noninferiority trial.
Eur J Anaesthesiol . 2024 Mar 1;41(3):217-225.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Two hundred and twenty-eight patients with primary total hip arthroplasty were randomized to receive either oral tranexamic acid (oral TXA; n=114) or 1 g of intravenous TXA (IV TXA; n=114). The primary outcome of interest was total blood loss (TBL) intra-operatively and up to 48 hours postoperatively. Secondary outcomes included a hemoglobin concentration decrease, D-Dimer levels on days 1 and 3, ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.